Rabeprazole (API)
Benzoimidazole-class PPI API manufactured under WHO-GMP. Offers low related substances and is optimised for rapid conversion to enteric pellets or tablets.
Product overview
Rabeprazole (API) — API for Pharmaceutical Formulation and Bulk Supply. Rraynex supplies Rabeprazole (API) api for pharmaceutical manufacturers, CDMOs and formulation developers requiring consistent particle characteristics, controlled release and reliable downstream processing. Overview: Rabeprazole (API) is supplied as api within the Anti-Ulcerant category. Rraynex focuses on controlled manufacturing, particle-size distribution, assay uniformity and appropriate release characteristics to support capsule filling, sachet and other multiparticulate dosage forms. Technical specifications are available upon request. Key Features & Benefits: • Consistent api characteristics for capsule filling and multiparticulate processing. • Controlled assay, moisture and related-substances parameters. • Suitable for formulation development and commercial manufacturing. • Technical support for formulation, scale-up and regulatory documentation. Applications: • Pharmaceutical manufacturers producing Anti-Ulcerant formulations. • CDMOs and formulation developers requiring bulk Rabeprazole (API) api. • Companies seeking WHO-GMP manufactured pharmaceutical api for export and commercial supply. Technical Specifications are available upon request. Available strengths: various strengths. Grade: IP / BP / USP / EP. Packaging: 25/50 kg. Storage: Store in cool, dry place protected from moisture.
Technical & formulation advantages
- Controlled pelletization and coating for reproducible dissolution and downstream handling.
- Uniform particle size and morphology suitable for capsule filling and multiparticulate systems.
- Manufactured under WHO-GMP with in-process controls on assay, moisture and related substances.
- Technical support for formulation development, scale-up and regulatory documentation.
Technical specifications are available upon request.
Applications
- Capsule filling and multiparticulate dosage forms (including MUPS where applicable).
- Pharmaceutical formulation and commercial manufacturing for Anti-Ulcerant therapies.
- CDMO and contract manufacturing programs requiring bulk rabeprazole (api).
Bulk pharmaceutical supply & commercial manufacture
Rraynex operates as a pharmaceutical pellets manufacturer and supplier based in India, supporting bulk supply, export and contract manufacturing for Rabeprazole (API). Supply is available in standard 25/50 kg packaging with batch traceability. Export documentation, DMF/COA access procedures and stability information are provided on request for applicable products.
Contact Rraynex for bulk pellet supply • View manufacturing capabilities
Bulk pharmaceutical supply & product enquiries
Looking to source Rabeprazole (API) in bulk? Rraynex supports pharmaceutical companies seeking Rabeprazole (API) for formulation development, capsule filling and commercial pharmaceutical manufacturing. Buyers can request product specifications, available strengths, technical documentation, samples where applicable, commercial quotations and bulk supply information.
- product specifications
- available strengths
- technical documentation
- samples where applicable
- commercial quotations
- bulk supply information
B2B supply only — not a consumer pharmacy. Pricing available on request for bulk quantities.
Related capabilities
Related products
Technical specifications
- Grade
- IP / BP / USP / EP
- Type
- API
- Category
- Anti-Ulcerant
- Pack size
- 25/50 kg
- Available strengths
- Custom / On request — Technical specifications are available upon request.
- Certifications
- WHO-GMP, ISO 9001, ISO 14001
Only use specification terms supported by existing product data. Additional technical documentation is available upon request.